Delivery Order SPE2DB22D1017-SPE2DB25FG6EH

Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ISOTRETINOIN 30 MG CAPSULE 10S, a pharmaceutical product, with a ceiling value of $1,222.50 and a performance period ending on May 14, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a $1,412.70 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a completion date of May 22, 2025. The contract is a firm fixed-price type and is not set-aside. Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $2,937.58 and a period of performance extending through May 20, 2025. The contract is not set aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, with a ceiling value of $6,540.03 and a period of performance through July 3, 2025. This contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of ISOTRETINOIN 40 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $1,120.50. The contract is a Firm Fixed Price Delivery Order with a period of performance through June 17, 2025. The contract is not set aside and is open to full and open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $3,320.30. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 10S, a pharmaceutical product, with a ceiling value of $1,048.71 and a period of performance through July 1, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 40 MG CAPSULE 30S, a prescription medication, with a ceiling value of $1,913.04 and a period of performance through June 24, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ISOTRETINOIN 30 MG CAPSULE 30S. The contract has a ceiling value of $3,937.85 and runs through May 5, 2023. It is a Firm Fixed Price contract, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,901,744 units of isotretinoin 30 mg capsules, with a ceiling value of $3,931.93. The contract type is Firm Fixed Price and the pricing type is Firm Fixed Price. The ultimate completion date for this order is November 28, 2023. This delivery order is part...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG6EH
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ISOTRETINOIN 30 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $3,956.40 and a performance period ending on July 1, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and the U.S. Coast Guard.

Generated 10/5/25, 12:58 AM